Cervical cancer is the fourth largest malignant tumor among women in the world. Human
papillomavirus (HPV) infection can lead to cervical intraepithelial neoplasia (CIN) and …

Simple Summary The role of human papillomavirus (HPV) in cervical carcinogenesis is
widely documented; however, with an increasing number of scientific publications on the …

Background HPV screening tests may improve cervical cancer risk stratification and better
guide decisions about follow-up with colposcopy/biopsy. This study aimed to estimate the …

Human papillomavirus is a predominant sexually transmitted viral pathogen. Our objective
was to analyze the relative distribution of genotypes over time and to determine the …

Introduction Persistent HR-HPV (high-risk human papillomavirus) infection is the main cause
of cervical cancer. The HPV oncogene E7 plays a key role in HPV tumorigenesis. At present …

Nucleic acid-based analytical bioplatforms have gained importance as diagnostic tests for
genomics and as early detection tools for diseases such as cancer. In this context, we report …

Cervical cancer is the fourth most common cancer in women worldwide and is caused by
persistent infection with high‐risk types of human papillomavirus (HPV). HPV viral load, the …

Résumé Le dépistage du cancer du col de l'utérus a connu de récentes avancées en France
avec l'organisation d'un programme national de dépistage et la révision des modalités de …

The positive clinical threshold of human papillomavirus (HPV) tests validated for primary
cervical cancer screening (CCS) is designed to offer an optimal balance between clinical …

Human papillomavirus (HPV) 16 is the most oncogenic biological agents for humans.
However, essential quantitative aspects of its infection cycle remain inadequately …